NCT/Study#

NCT03919071 /

COG-ACNS1723

A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in ACTIVEly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG)

A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in ACTIVEly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG)

DISEASE GROUP:
Pediatric Oncology
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: